What is Mineralys Therapeutics, Inc.'s intangibles (net)?

Mineralys Therapeutics, Inc. (MLYS) reported intangibles (net) of $1.82M in Q4 2025.

What is the long-term trend for Mineralys Therapeutics, Inc.'s intangibles (net)?

Over 3 years (2022 to 2025), Mineralys Therapeutics, Inc.'s intangibles (net) has grown at a 89.0% compound annual growth rate (CAGR), from $270K to $1.82M.

What does intangibles (net) mean?

Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.

Mineralys Therapeutics, Inc. MLYS Intangibles (Net)

Intangibles (Net) at other companies

Aurinia PharmaceuticalsAUPH

$3.59M-13.7%

Kiniksa Pharmaceuticals International, plcKNSA

$15M-6.3%

Tenet HealthcareTHC

$432M-16.6%

MedtronicMDT

$10.15B-13.0%

Eli LillyLLY

$7.37B+22.7%

ITG

Integer HoldingsITGR

$716.05M-6.5%

Other financials

Income statement

See full

Operating income-$45.3M-2.0%

Net income-$39.3M+6.8%

EPS (diluted)-$0.47+40.5%

Balance sheet

See full

Cash & equivalents$1.2M-14.6%

Total equity$638.1M+86.8%

Total assets$652.9M+83.9%

Cash flow

See full

Operating cash flow-$39.5M+13.2%

CapEx$15.0K—

Free cash flow-$37.9M+43.3%

Valuation

See full

Market cap$2.27B+124%

Returns & leverage

See full

Return on equity-31%-9.6pp

Current ratio44.3×+17.8×

Where this comes from

Reported directly by Mineralys Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets.

The official record: Mineralys Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mineralys Therapeutics, Inc.'s intangibles (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Mineralys Therapeutics, Inc.'s intangibles (net)?: Mineralys Therapeutics, Inc. (MLYS) reported intangibles (net) of $1.82M in Q4 2025.
What is the long-term trend for Mineralys Therapeutics, Inc.'s intangibles (net)?: Over 3 years (2022 to 2025), Mineralys Therapeutics, Inc.'s intangibles (net) has grown at a 89.0% compound annual growth rate (CAGR), from $270K to $1.82M.
What does intangibles (net) mean?: Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.